Perioperative Blood Product Transfusions in Gastric Cancer Surgery in Finland
Digestive Surgery · 2025
DOI: 10.1159/000549881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Surgery, 2025. Verfasst von Jukka-Pekka Lammi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Kuopio University Hospital, Kuopio, Finland, pekka.lammi@pshyvinvointialue.fi. Hauptthemen laut MEDLINE: Stomach Neoplasms, Anemia, Blood Transfusion, Gastrectomy. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Introduction
Preoperative anaemia is common in gastric cancer patients. Although restrictive blood product transfusion strategies have been introduced, their use in standard practice is not well known. This national register study investigated the perioperative haemoglobin and platelet levels and the use of blood product transfusions in gastric cancer surgery.
Methods
In order to improve and unify blood transfusion policies, the Finnish Red Cross Blood Service carried out a project concerning the optimal use of blood products (VOK project). These register data were used to form the patient population containing 70% of blood product transfusions in Finland. Patients undergoing open surgery for gastric cancers were included.
Results
A total of 500 patients were included. Perioperative anaemia was observed in 75% of males and 52% of females. Fifty-one percent of patients received blood transfusions, with a median transfusion trigger point of 91 g/L [IQR 84–98 g/L] and a median 3 units transfused [IQR 2–4 units]. Seven percent received platelet transfusion (median trigger 77, IQR 15–146; median 4 units, IQR 2–8), and 6.5% received either fresh frozen plasma or pooled human plasma products. At discharge, the median haemoglobin level was 109 g/L in non-transfused patients and 114 g/L in transfused patients. If restrictive strategies had been applied, only 1.7% (n = 9) had required blood and 0.5% (n = 3) had a platelet transfusion.
Conclusion
Anaemia is common among patients undergoing gastric cancer surgery. We encourage clinicians to follow restrictive transfusion policies in gastric cancer patients as Hb levels seem to recover after gastric surgery without blood transfusions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Kuopio University Hospital, Kuopio, Finland, pekka.lammi@pshyvinvointialue.fi.
- Department of Surgery, Kuopio University Hospital, Kuopio, Finland.
- Department of Surgery, Hospital Nova, Wellbeing Services County of Central Finland, Jyväskylä, Finland.
- Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
- School of Medicine, University of Eastern Finland, Kuopio, Finland.
- Department of Surgery, Oulu University Hospital, Oulu, Finland.
Zitieren
APA
Lammi, J. P., Ukkonen, M., Eskelinen, M., Saarnio, J., Käkelä, P., & Rantanen, T. (2025). Perioperative Blood Product Transfusions in Gastric Cancer Surgery in Finland. Digestive Surgery. https://doi.org/10.1159/000549881
Vancouver
Lammi JP, Ukkonen M, Eskelinen M, Saarnio J, Käkelä P, Rantanen T. Perioperative Blood Product Transfusions in Gastric Cancer Surgery in Finland. Digestive Surgery. 2025. doi:10.1159/000549881
BibTeX
@article{Lammi2025,
author = {Lammi, Jukka-Pekka and Ukkonen, Mika and Eskelinen, Matti and Saarnio, Juha and Käkelä, Pirjo and Rantanen, Tuomo},
title = {Perioperative Blood Product Transfusions in Gastric Cancer Surgery in Finland},
journal = {Digestive Surgery},
year = {2025},
doi = {10.1159/000549881}
}
EUVIMED